(VIANEWS) – Shares of 10x Genomics (NASDAQ: TXG) fell 5.01% to $98.79 at 11:46 EST on Tuesday, after five successive sessions in a row of losses. NASDAQ is sliding 1.93% to $14,606.81, following the last session’s upward trend. This seems, up to now, an all-around down trend exchanging session today.
10x Genomics’s last close was $104.00, 50.24% below its 52-week high of $208.99.
Today’s last reported volume for 10x Genomics is 562905 which is 26.5% below its average volume of 765958.
10x Genomics’s Sales
10x Genomics’s sales growth is 78.1% for the present quarter and 33.2% for the next. The company’s growth estimates for the present quarter and the next is 70.8% and 97.2%, respectively.
10x Genomics’s Revenue
Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.
10x Genomics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.59%, a negative 1.81%, and a positive 3.03%, respectively.
10x Genomics’s highest amplitude of average volatility was 5.59% (last week), 2.80% (last month), and 3.03% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
10x Genomics’s stock is considered to be overbought (>=80).
10x Genomics’s Stock Yearly Top and Bottom Value
10x Genomics’s stock is valued at $98.79 at 11:46 EST, way below its 52-week low of $128.15.
10x Genomics’s Moving Average
10x Genomics’s value is way below its 50-day moving average of $155.93 and way below its 200-day moving average of $170.12.
More news about 10x Genomics (TXG).